Analysis of transcriptional regulation by progesterone receptor in ER-positive breast cancer cells by ChIP-Seq

被引：0
|
作者：
Yang, Fan
Bilke, Sven
Pineda, Marbin
Walker, Bob
Zhu, Jack
Meltzer, Paul
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4612
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4612
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Motif prediction of abemaciclib in a breast cancer cell line using ChIP-Seq data analysis
    Deep, Utkarsh
    Yadav, Ruchi
    BIOMEDICAL RESEARCH AND THERAPY, 2022, 9 (03):
  • [32] Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer
    Ruan, Xiangyan
    Zhang, Ying
    Mueck, Alfred O.
    Willibald, Marina
    Seeger, Harald
    Fehm, Tanja
    Brucker, Sara
    Neubauer, Hans
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (02): : 203 - 209
  • [33] Chronic CXCL12 exposure induces a metastatic phenotype in ER-positive breast cancer cells through transcriptional reprogramming
    Sun, J.
    Slingerland, J. M.
    Lippman, M. E.
    CANCER RESEARCH, 2017, 77
  • [34] Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer:: Specific correlation with progesterone receptor
    Saji, S
    Omoto, Y
    Shimizu, C
    Warner, M
    Hayashi, Y
    Horiguchi, S
    Watanabe, T
    Hayashi, S
    Gustafsson, JÅ
    Toi, M
    CANCER RESEARCH, 2002, 62 (17) : 4849 - 4853
  • [35] Transcriptional Changes Induced by Anastrozole and Fulvestrant Treatment in ER-Positive Breast Cancers
    Ghazoui, Z.
    Anderson, H.
    Dunbier, A.
    Anderson, E.
    Lindemann, J.
    Wellings, B.
    Walker, J.
    Kuter, I.
    Dowsett, M.
    CANCER RESEARCH, 2010, 70
  • [36] Elevated GRHL2 Imparts Plasticity in ER-Positive Breast Cancer Cells
    Zheng, Christy
    Allen, Kaelyn O.
    Liu, Tianrui
    Solodin, Natalia M.
    Meyer, Mark B.
    Salem, Kelley
    Tsourkas, Phillipos K.
    McIlwain, Sean J.
    Vera, Jessica M.
    Cromwell, Erika R.
    Ozers, Mary Szatkowski
    Fowler, Amy M.
    Alarid, Elaine T.
    CANCERS, 2024, 16 (16)
  • [37] A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis
    Neven, Patrick
    Van Gorp, Toon
    Deraedt, Karen
    BREAST CANCER RESEARCH, 2008, 10 (05)
  • [38] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [39] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Alomran, Reem
    White, Michelle
    Bruce, Melissa
    Bressel, Mathias
    Roache, Susan
    Karroum, Lama
    Hanna, Gerard G.
    Siva, Shankar
    Goel, Shom
    David, Steven
    BMC CANCER, 2021, 21 (01)
  • [40] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
12345